Insights: Clients

Drug Pricing/TrumpRx (Direct-to-Consumer)

The Trump administration is considering creating a government-run website which would facilitate the purchase of certain pharmaceuticals by consumers at discounted cash prices – a direct-to-consumer (DTC) construct that would presumably bypass pharmacy benefit managers (PBMs) and/or insurance companies. The plan has not yet been finalized and is...

Pharmaceutical Tariffs

President Trump yesterday posted... "Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America. “IS BUILDING” will be defined as, “breaking ground” and/or “under construction.”

Tech / Media / Telecom

Antitrust (Google, Meta, Apple, Amazon)

The DOJ’s antitrust actions against Google have continued to advance this month. Earlier this month, the District Court for D.C. issued a series of remedies against Google following its finding last summer that the company illegally maintained a monopoly in the “general search services and general text advertising” markets. And this week, the...

Tech / Media / Telecom

Tech Workforce/H-1B Visas

Late last week, President Trump signed an Executive Order (EO) imposing a new, incremental $100,000 fee for H-1B petitions. Two days later, the Department of Homeland Security (DHS) – as directed by the EO – issued a proposed rulemaking to implement a weighted selection process that would generally favor the allocation of H-1B visas to higher...

Healthcare, Macro

Fiscal Year 2026 Funding/Government Shutdown, ACA

At the urging of Republican leaders, President Trump cancelled a meeting this week with Democratic leaders to address the need to pass appropriations legislation to fund government operations past the 10/1 beginning of FY26. If appropriations legislation is not passed by 9/30, government operations (e.g., discretionary programs such as...

Mergers & Acquisitions

Baker Hughes/Chart Industries

The transaction’s initial 30-day HSR waiting period is scheduled to expire on October 3. The DOJ historically has had jurisdiction over energy products and services mergers and will likely review this deal as well.